nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts of the 27th Annual Conference of APASL, March 14–18, 2018, New Delhi, India
|
|
|
2018 |
|
supplement-2 |
p. 181-661 |
artikel |
2 |
Alcohol, TLR4-TGF-β antagonism, and liver cancer
|
Tsukamoto, Hidekazu |
|
2013 |
|
supplement-2 |
p. 408-412 |
artikel |
3 |
An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis
|
Sanyal, Arun J. |
|
2014 |
|
supplement-2 |
p. 800-805 |
artikel |
4 |
Bacterial infections in cirrhosis
|
Botwin, Gregory J. |
|
2014 |
|
supplement-2 |
p. 467-474 |
artikel |
5 |
Basis of HBV persistence and new treatment options
|
Thursz, Mark |
|
2013 |
|
supplement-2 |
p. 486-491 |
artikel |
6 |
Current histological classification of NAFLD: strength and limitations
|
Bedossa, Pierre |
|
2014 |
|
supplement-2 |
p. 765-770 |
artikel |
7 |
Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments
|
Yamasaki, Takahiro |
|
2014 |
|
supplement-2 |
p. 492-498 |
artikel |
8 |
Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
|
Duseja, Ajay |
|
2014 |
|
supplement-2 |
p. 755-764 |
artikel |
9 |
Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury
|
Aroor, Annayya R. |
|
2014 |
|
supplement-2 |
p. 421-430 |
artikel |
10 |
Erratum to: Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury
|
Aroor, Annayya R. |
|
2014 |
|
supplement-2 |
p. 431 |
artikel |
11 |
Foreword to the proceedings of the 8th international ALPD symposium, New Delhi, India, November 15–17, 2013
|
|
|
2014 |
|
supplement-2 |
p. 407 |
artikel |
12 |
Growth factors enhance liver regeneration in acute-on-chronic liver failure
|
Kedarisetty, Chandan Kumar |
|
2014 |
|
supplement-2 |
p. 514-525 |
artikel |
13 |
Hard clinical outcomes in patients with NAFLD
|
Kumar, Ramesh |
|
2014 |
|
supplement-2 |
p. 790-799 |
artikel |
14 |
Hepatocyte-mediated cytotoxicity and host defense mechanisms in the alcohol-injured liver
|
McVicker, Benita L. |
|
2013 |
|
supplement-2 |
p. 432-438 |
artikel |
15 |
Immune and inflammatory pathways in NASH
|
Ganz, Michal |
|
2014 |
|
supplement-2 |
p. 771-781 |
artikel |
16 |
Immune therapy for hepatocellular carcinoma
|
Ilan, Yaron |
|
2013 |
|
supplement-2 |
p. 499-504 |
artikel |
17 |
Immunity and inflammatory signaling in alcoholic liver disease
|
Mandrekar, Pranoti |
|
2014 |
|
supplement-2 |
p. 439-446 |
artikel |
18 |
Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH
|
Montesi, Luca |
|
2014 |
|
supplement-2 |
p. 814-822 |
artikel |
19 |
Insulin resistance, steatosis and hepatitis C virus
|
Mangia, Alessandra |
|
2014 |
|
supplement-2 |
p. 782-789 |
artikel |
20 |
Lean NASH: distinctiveness and clinical implication
|
Das, Kausik |
|
2014 |
|
supplement-2 |
p. 806-813 |
artikel |
21 |
Liver dialysis in acute-on-chronic liver failure: current and future perspectives
|
Maiwall, Rakhi |
|
2014 |
|
supplement-2 |
p. 505-513 |
artikel |
22 |
Liver transplantation for alcoholic hepatitis. Current situation and future
|
Gelu-Simeon, Moana |
|
2013 |
|
supplement-2 |
p. 481-485 |
artikel |
23 |
Mechanisms of alcohol-induced hepatocellular carcinoma
|
Sidharthan, Sreetha |
|
2013 |
|
supplement-2 |
p. 452-457 |
artikel |
24 |
New drug targets for alcoholic liver disease
|
Xu, Mingjiang |
|
2014 |
|
supplement-2 |
p. 475-480 |
artikel |
25 |
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific
|
Vongsuvanh, Roslyn |
|
2014 |
|
supplement-2 |
p. 823-832 |
artikel |
26 |
Novel modulators of hepatosteatosis, inflammation and fibrogenesis
|
Lakshman, M. Raj |
|
2014 |
|
supplement-2 |
p. 413-420 |
artikel |
27 |
Organ dysfunctions in patients with alcoholic cirrhosis
|
Moreau, Richard |
|
2014 |
|
supplement-2 |
p. 464-466 |
artikel |
28 |
Pharmacological agents for nonalcoholic steatohepatitis
|
Guillaume, Maeva |
|
2014 |
|
supplement-2 |
p. 833-841 |
artikel |
29 |
Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view
|
Nguyen, Douglas L. |
|
2013 |
|
supplement-2 |
p. 447-451 |
artikel |
30 |
Recent insights into hepatic cancer stem cells
|
Anfuso, Beatrice |
|
2013 |
|
supplement-2 |
p. 458-463 |
artikel |